Table 2. Univariate and multivariate analysis of items on overall survival of pancreatic cancer patients.
| Variable | Univariate analysis | Multi-factor analysis | |||
|---|---|---|---|---|---|
| HR (95% CI) | P value | HR (95% CI) | P value | ||
| Sex | |||||
| Male vs. female | 0.968 (0.458–2.049) | 0.932 | |||
| Age (year) | |||||
| >65 vs. ≤65 | 0.938 (0.423–2.079) | 0.874 | |||
| Tumor site | |||||
| Head vs. body/tail | 1.755 (0.808–3.811) | 0.155 | |||
| Histological grade | |||||
| 1/2 vs. 3 | 1.182 (0.548–2.551) | 0.669 | |||
| T classification | |||||
| I/ II vs. III/IV | 1.015 (0.428–2.409) | 0.973 | |||
| Lymph node | |||||
| − vs. + | 0.920 (0.412–2.054) | 0.838 | |||
| Distant metastasis | |||||
| − vs. + | 0.212 (0.073–0.614) | 0.004 | 0.240 (0.082–0.702) | 0.009 | |
| TNM staging | |||||
| I/II vs. III/IV | 0.986 (0.391–2.486) | 0.976 | |||
| FAPα | |||||
| Low vs. high expression | 3.629 (1.479–8.904) | 0.005 | 3.013 (1.240–7.319) | 0.015 | |